Front Page
 

2015 MAPD and PDP open enrollment
Find a Medicare seminar near you
How you can help fight Medicare fraud
How doctors fight Medicare fraud
How we fight Medicare fraud
When BCBSTX calls
BCBSTX grants support healthy kids, families
Cheap drugs aren't always a good deal
 

Get your flu shot, pneumonia too
What to do with outdated drugs
Tips for taking drugs safely
Treat cholesterol to treat diabetes
Link between stress, depression and heart health
 
How to have a healthier holiday
Why you should gather important documents
Download an important documents checklist
When friends move away
Surviving empty nest syndrome
Keep everyone updated with Caring Bridge
What to see, eat and buy in Santa Fe
Understanding Native Americans
Dramatic depiction of slavery
Women and war
 
Restaurant safety
Food safety at home
How to safely cut a melon
 
 
Play our 'Mystery Game'
Crossword puzzle
Sudoku puzzle
Word search puzzle
 
 
Medicare Basics
Recent News
Current Issue
Previous Issues
About LifeTimes Newsletter
Sign up to get LifeTimes by email
 


  facebook twitter youtube
  Learn more


 
Share |
Latest News

FDA issues update on osteoporosis drugs

Heart Health

Bisphosphonates, drugs used effectively to treat osteoporosis, have been widely prescribed since 1995. But questions linger about possible problems with their long-term use. (Prescribed under several brand names as well as generics, bisphosphonates carry safety warnings about potential risks for jawbone decay and thigh bone fractures.)

Now, an update on the U.S. Food and Drug Administration’s Consumer Updates website suggests some bisphosphonate users may be able to stop taking the drugs after three to five years, yet keep benefiting from their use, because the drugs can stay in bones for years.

FDA researchers base their report on a survey of clinical studies involving bone mineral density and fractures in men and women who had been taking bisphosphonates for three to 10 years.

(NOTE: Researchers stress highly more investigation is needed, and osteoporosis patients taking bisphosphonates should consult their doctors about specific health needs.)

For example, "Patients at increased risk for fractures (like older patients with a history of fracture and sub-normal bone density) may benefit further from continued bisphosphonate therapy," the FDA says.

To read the full report, "How Long Should You Take Osteoporosis Drugs?" visit www.fda.gov, click on "For Consumers and Patients," then search for "osteoporosis."